PL3157911T3 - Nowe fluorochinolony i ich zastosowanie w leczeniu infekcji bakteryjnych - Google Patents

Nowe fluorochinolony i ich zastosowanie w leczeniu infekcji bakteryjnych

Info

Publication number
PL3157911T3
PL3157911T3 PL15729510T PL15729510T PL3157911T3 PL 3157911 T3 PL3157911 T3 PL 3157911T3 PL 15729510 T PL15729510 T PL 15729510T PL 15729510 T PL15729510 T PL 15729510T PL 3157911 T3 PL3157911 T3 PL 3157911T3
Authority
PL
Poland
Prior art keywords
bacterial infections
treat bacterial
fluoroquinolones
novel
novel fluoroquinolones
Prior art date
Application number
PL15729510T
Other languages
English (en)
Inventor
Alexandra AUBRY
Guillaume ANQUETIN
Original Assignee
Sorbonne Universite
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sorbonne Universite filed Critical Sorbonne Universite
Publication of PL3157911T3 publication Critical patent/PL3157911T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL15729510T 2014-06-18 2015-06-18 Nowe fluorochinolony i ich zastosowanie w leczeniu infekcji bakteryjnych PL3157911T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14173040.8A EP2957561A1 (en) 2014-06-18 2014-06-18 Novel fluoroquinolones and use thereof to treat bacterial infections
EP15729510.6A EP3157911B1 (en) 2014-06-18 2015-06-18 Novel fluoroquinolones and use thereof to treat bacterial infections
PCT/EP2015/063752 WO2015193454A1 (en) 2014-06-18 2015-06-18 Novel fluoroquinolones and use thereof to treat bacterial infections

Publications (1)

Publication Number Publication Date
PL3157911T3 true PL3157911T3 (pl) 2020-07-13

Family

ID=50972561

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15729510T PL3157911T3 (pl) 2014-06-18 2015-06-18 Nowe fluorochinolony i ich zastosowanie w leczeniu infekcji bakteryjnych

Country Status (10)

Country Link
US (1) US10087165B2 (pl)
EP (2) EP2957561A1 (pl)
CN (1) CN106660990B (pl)
BR (1) BR112016029619B1 (pl)
CA (1) CA2952300C (pl)
ES (1) ES2769827T3 (pl)
PL (1) PL3157911T3 (pl)
RU (1) RU2723545C2 (pl)
WO (1) WO2015193454A1 (pl)
ZA (1) ZA201608607B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2636751C1 (ru) * 2016-11-02 2017-12-01 федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) Антибактериальные средства на основе производных ципрофлоксацина
CN110551124B (zh) * 2019-06-14 2021-01-08 山东省联合农药工业有限公司 一种喹诺酮类化合物或其农药学上可接受的盐及其制备方法与用途
EP4178955A1 (en) 2020-07-11 2023-05-17 Pfizer Inc. Antiviral heteroaryl ketone derivatives
US11351149B2 (en) 2020-09-03 2022-06-07 Pfizer Inc. Nitrile-containing antiviral compounds
CA3199670A1 (en) 2020-10-28 2022-05-05 The Kroger Co. Freshness sensor devices and related methods

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670444B1 (en) 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
DE3033157A1 (de) 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3248505A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7(4- (oxoalkyl)-1-piperazinyl/-3-chinolincarbonsaeuren und ihre derivate, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3248507A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen Mikrobizide mittel auf chinoloncarbonsaeure basis
DE3306771A1 (de) * 1983-02-25 1984-08-30 Bayer Ag, 5090 Leverkusen Chinoloncarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
CN1014410B (zh) * 1984-06-04 1991-10-23 拜尔股份公司 制备7-(3-取代-1-哌嗪基)-3-喹诺酮羧酸的方法
DE3542002A1 (de) * 1985-11-28 1987-06-04 Bayer Ag 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
JPH089597B2 (ja) 1986-01-21 1996-01-31 杏林製薬株式会社 選択毒性に優れた8‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法
IL90062A (en) * 1988-04-27 1994-10-07 Daiichi Seiyaku Co Pyridonecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
DE3906365A1 (de) 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
US5972379A (en) * 1995-02-14 1999-10-26 Sequus Pharmaceuticals, Inc. Liposome composition and method for administering a quinolone
CN100341855C (zh) * 2005-02-22 2007-10-10 南京澳新医药科技有限公司 7-取代-8-甲氧基氟喹诺酮羧酸衍生物、制法、制剂及其用途

Also Published As

Publication number Publication date
CA2952300C (en) 2022-06-28
ZA201608607B (en) 2020-05-27
EP3157911A1 (en) 2017-04-26
BR112016029619A8 (pt) 2022-10-18
RU2017100506A3 (pl) 2019-01-30
ES2769827T3 (es) 2020-06-29
US10087165B2 (en) 2018-10-02
US20170144992A1 (en) 2017-05-25
EP2957561A1 (en) 2015-12-23
BR112016029619A2 (pt) 2017-08-22
RU2723545C2 (ru) 2020-06-16
CA2952300A1 (en) 2015-12-23
CN106660990A (zh) 2017-05-10
WO2015193454A1 (en) 2015-12-23
EP3157911B1 (en) 2019-12-04
BR112016029619B1 (pt) 2022-11-16
RU2017100506A (ru) 2018-07-20
CN106660990B (zh) 2019-10-18

Similar Documents

Publication Publication Date Title
EP3881680B8 (en) Methods and compositions relating to microbial treatment
GB2554629B8 (en) Prevention and treatment of microbial infections
PT3074027T (pt) Composições bacterianas sinérgicas e métodos de produção e utilização das mesmas
GB201411197D0 (en) Composition and use thereof
HUE060941T2 (hu) Halogénolefin-bázisú készítmény és alkalmazása
SG11201609652RA (en) Treatment of polybacterials infections
HUE044061T2 (hu) Kombinációs terápia rezisztens bakteriális fertõzések kezelésére
EP3133919A4 (en) Agents and methods for treatment of pathogens
EP3130582B8 (en) Compound having immune disease treatment effect and use thereof
PT3102218T (pt) Conjunto de dobradiças para uma porta de vidro isolado
SG11201607600TA (en) Vaginal composition and use thereof
ZA201703398B (en) Pharmaceutical composition and methods
ZA201604870B (en) Recombinant microorganisms and methods of use thereof
ZA201503474B (en) Compositions and methods for treating bacterial infections
SMT201900692T1 (it) Composizione per l'uso del trattamento delle infezioni batteriche
ZA201608607B (en) Novel fluoroquinolones and use thereof to treat bacterial infections
PT3285787T (pt) Tratamento de infeções bacterianas em aquicultura
EP3190893A4 (en) Compositions and methods for treating and preventing bacterial infections
GB201411196D0 (en) Composition and use thereof
IL246587A0 (en) Preparations for use in the treatment of allergic conditions
GB201406172D0 (en) Therapy and pharmaceutical composition
PL2862576T3 (pl) Drobnoustroje i zawierające je kompozycje do stosowania do leczenia lub profilaktyki zapalenia sutka
PT3160263T (pt) Composições para prevenção de infeções
IL253418A0 (en) Nisin-based compounds and their use in the treatment of bacterial infections
ZA201608775B (en) Hair treatment composition